Evaluation of de-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: Reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and de-O-acetylated serogroup C strains

被引:77
作者
Richmond, P
Borrow, R
Findlow, J
Martin, S
Thornton, C
Cartwright, K
Miller, E
机构
[1] Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England
[2] Univ Western Australia, Princess Margaret Hosp Children, Dept Paediat, Perth, WA 6014, Australia
[3] Inst Child Hlth, Immunobiol Unit, London WC1N 2AN, England
[4] Withington Hosp, PHLS Meningococcal Reference Unit, Manchester M20 2LR, Lancs, England
[5] Publ Hlth Lab Serv, Ctr Appl Microbiol & Res, Salisbury SP4 0JG, Wilts, England
[6] Gloucestershire Royal Hosp, Publ Hlth Lab, Gloucester Vaccine Evaluat Unit, Gloucester GL1 3NN, England
关键词
D O I
10.1128/IAI.69.4.2378-2382.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The polysaccharide capsule of serogroup C Neisseria meningitidis (MenC) has been integral to vaccine development. Licensed MenC vaccines contain the O-acetylated (OAc+) form of polysaccharide. Some MenC strains have de-O-acetylated (OAc-) polysaccharide, which may affect antibody specificity and functional activity when used in a vaccine. We evaluated an OAc-MenC conjugate-tetanus toroid conjugate (MCC-TT) vaccine given concomitantly with whole-cell diphtheria-tetanus-pertussis, Haemophilus influenzae type b, and oral polio immunization in 83 infants at 2, 3, and 4 months of age. Serum bactericidal activities (SBA) against OAc+ and OAc- MenC strains and OAc+ and OAc- polysaccharide-specific immunoglobulin G (IgG) levels were evaluated. MCC-TT vaccine was well tolerated. All infants produced SEA titers of greater than or equal to8 after a single dose at 2 months of age. The SEA geometric mean titer for OAc+ strain C11 increased from 2.7 (95% confidence interval [CI] 2.2 to 3.2) to 320 (95% CI, 237 to 432), 773 (95% CI, 609 to 982), and 1,063 (95% CI, 856 to 1319) after one, two, and three doses of MCC-TT, respectively. OAc- IgG levels were twice as high as OAc+ IgG levels after the primary series of MCC-TT vaccine, and the SEA was significantly higher against the OAc-MenC strain. Antibody responses to booster vaccination with either OAc+ MenC polysaccharide vaccine (MACP) or a fourth dose of MCC-TT at 14 months of age provided evidence of immunologic memory. The acetylation status of the booster vaccine influenced the specificity of the response, with significantly higher OAc- IgG levels and SEA after MCC-TT vaccine compared to MACP vaccine but similar OAc+ antibody levels. MCC-TT vaccine is highly immunogenic and primes for immunologic memory against OAc+ and OAc-MenC strains in infancy.
引用
收藏
页码:2378 / 2382
页数:5
相关论文
共 33 条
[1]   SPECIFICITY OF ANTIBODIES TO O-ACETYL-POSITIVE AND O-ACETYL-NEGATIVE GROUP-C MENINGOCOCCAL POLYSACCHARIDES IN SERA FROM VACCINEES AND CARRIERS [J].
ARAKERE, G ;
FRASCH, CE .
INFECTION AND IMMUNITY, 1991, 59 (12) :4349-4356
[2]   PREVENTION OF MENINGOCOCCAL DISEASE BY GROUP-C POLYSACCHARIDE VACCINE [J].
ARTENSTEIN, MS ;
GOLD, R ;
ZIMMERLY, JG ;
WYLE, FA ;
SCHNEIDER, H ;
HARKINS, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (08) :417-+
[3]   ANTIBODY-RESPONSES AND SYMPTOMS AFTER DTP AND EITHER TETANUS OR DIPHTHERIA HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES GIVEN FOR PRIMARY IMMUNIZATION BY SEPARATE OR MIXED INJECTION [J].
BEGG, NT ;
MILLER, E ;
FAIRLEY, CK ;
CHAPEL, HM ;
GRIFFITHS, H ;
WAIGHT, PA ;
ASHWORTH, LAE .
VACCINE, 1995, 13 (16) :1547-1550
[4]   Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster [J].
Booy, R ;
Heath, PT ;
Slack, MPE ;
Begg, N ;
Moxon, ER .
LANCET, 1997, 349 (9060) :1197-1202
[5]  
Borrow R, 2000, FEMS IMMUNOL MED MIC, V28, P79, DOI 10.1111/j.1574-695X.2000.tb01460.x
[6]  
Borrow R, 2000, FEMS IMMUNOL MED MIC, V28, P189, DOI 10.1111/j.1574-695X.2000.tb01475.x
[7]   Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants [J].
Dagan, R ;
Eskola, J ;
Leclerc, C ;
Leroy, O .
INFECTION AND IMMUNITY, 1998, 66 (05) :2093-2098
[8]   EVALUATION OF GROUP-C MENINGOCOCCAL POLYSACCHARIDE VACCINE IN MARINE RECRUITS, SAN-DIEGO, CALIFORNIA [J].
DEVINE, LF ;
PIERCE, WE ;
FLOYD, TM ;
RHODE, SL ;
EDWARDS, EA ;
SIESS, EE ;
PECKINPAUGH, RO .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1970, 92 (01) :25-+
[9]   Conjugate meningococcal serogroup A and C vaccine: Reactogenicity and immunogenicity in United Kingdom infants [J].
Fairley, CK ;
Begg, N ;
Borrow, R ;
Fox, AJ ;
Jones, DM ;
Cartwright, K .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1360-1363
[10]   MULTICENTER COMPARISON OF NEISSERIA-MENINGITIDIS SEROGROUP-C ANTI-CAPSULAR POLYSACCHARIDE ANTIBODY-LEVELS MEASURED BY A STANDARDIZED ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
GHEESLING, LL ;
CARLONE, GM ;
PAIS, LB ;
HOLDER, PF ;
MASLANKA, SE ;
PLIKAYTIS, BD ;
ACHTMAN, M ;
DENSEN, P ;
FRASCH, CE ;
KAYHTY, K ;
MAYS, JP ;
NENCIONI, L ;
PEETERS, C ;
PHIPPS, DC ;
POOLMAN, JT ;
ROSENQVIST, E ;
SIBER, GR ;
THIESEN, B ;
TAI, J ;
THOMPSON, CM ;
VELLA, PP ;
WENGER, JD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (06) :1475-1482